Shenzhen Hepalink Pharmaceutical Co., Ltd., Ten Percent Owner at Liminal BioSciences, holds 85.29M shares in Resverlogix (Ticker: TSE:RVX), holds 96.29M shares in Liminal BioSciences (Ticker: LMNL). Most recently, Shenzhen Hepalink Pharmaceutical Co., Ltd. Bought ― shares of Resverlogix on Aug 18, 2020 for an estimated value of 2.68M.
What was Shenzhen Hepalink Pharmaceutical Co., Ltd.’s latest transaction?
Shenzhen Hepalink Pharmaceutical Co., Ltd. latest transaction was an Informative Buy of C$2.68M.
What was Shenzhen Hepalink Pharmaceutical Co., Ltd.'s most profitable transaction?
Shenzhen Hepalink Pharmaceutical Co., Ltd.’s most profitable transaction was an Informative Buy of TSE:RVX stock on December 5, 2017. The return on the trade was 100.00%.
What is Shenzhen Hepalink Pharmaceutical Co., Ltd.'s role in Liminal BioSciences?
Shenzhen Hepalink Pharmaceutical Co., Ltd.'s role in Liminal BioSciences is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.